The Company is actively engaging with policy leaders in the U.S. and has been involved in ongoing constructive proposals regarding automotive policy, particularly involving the EV sector and FX’s new business strategy in the U.S. The Company recently announced that it has launched the start of assembly of the first FX Super One MPV pre-production vehicles at the Company’s Hanford, CA, factory in anticipation of the first pre-production vehicle off the line ceremony planned for December 21.WASHINGTON, Dec. 11, 2025 (GLOBE NEWSWIRE) — Faraday Future Intelligent Electric Inc. (Nasdaq: FFAI) (“FF”, “Faraday Future”, or the “Company”), a California-based global shared intelligent electric mobility ecosystem company, today announced that executives from FF and FX brands recently joined numerous members of Congress and political leadership...

Highlights:Robex delivers first ore to Kiniéro mill as part of commissioning activities Processing plant commissioning progressing in line with expectations Mechanical, electrical, and instrumentation systems performing in accordance with design Project remains on track for first gold pour in December 2025 Ramp-up to commercial production at Kiniéro targeted for Q1 2026.Figure 1: First ore being delivered to Kiniéro mill as part of commissioning activities QUEBEC CITY, Dec. 11, 2025 (GLOBE NEWSWIRE) — West African gold producer and developer Robex Resources Inc (“Robex” or the “Company”) (ASX: RXR | TSX-V: RBX) is pleased to report first ore has been delivered to the mill at its Kiniéro Gold Project (“Kiniéro”) in Guinea, West Africa ahead of first gold production, which is on track for this month. Commissioning at Kiniéro’s...

AUSTIN, Texas and NEW YORK, Dec. 11, 2025 (GLOBE NEWSWIRE) — T1 Energy Inc. (NYSE: TE) ( “T1,” “T1 Energy” or the “Company”) today announced the pricing of its previously announced underwritten public offerings of $140.0 million aggregate principal amount of its 5.25% convertible senior notes due 2030 (the “Convertible Notes” and such offering, the “Convertible Notes Offering”) and 28,282,830 shares of its common stock at a public offering price of $4.95 per share (the “Common Stock Offering” and together, the “Offerings”). The Convertible Notes Offering was upsized from the previously announced $120.0 million aggregate principal amount of Convertible Notes. The Company estimates that the net proceeds from the Offerings will be approximately $264.3 million, after deducting underwriting discounts and commissions and T1 Energy’s...

KUALA LUMPUR, Malaysia, Dec. 11, 2025 (GLOBE NEWSWIRE) — Treasure Global Inc. (NASDAQ: TGL) (“Treasure Global” or the “Company”), a Southeast Asia–anchored technology company, today announced the closing of its previously announced registered direct offering with certain institutional investors for the purchase and sale of 250,000 shares of its common stock, par value $0.00001 per share. The Company received total gross proceeds of USD 2,500,000, before deducting commissions and offering expenses. D. Boral Capital LLC acted as the exclusive placement agent for the offering. The offering was conducted under the Company’s shelf Registration Statement on Form S-3 (File No.333-278171) filed with the U.S. Securities and Exchange Commission (“SEC”) and declared effective on March 29, 2024. A final prospectus supplement and accompanying...

SAN JOSE, Calif., Dec. 11, 2025 (GLOBE NEWSWIRE) — Legence Corp. (Nasdaq: LGN) (“Legence” or the “Company”) today announced the pricing of an upsized secondary underwritten public offering (the “offering”) of 8,402,178 shares of its Class A common stock (“Common Stock”) by selling stockholders affiliated with Blackstone Inc. (the “Selling Stockholders”) at a price to the public of $45.00 per share. The Selling Stockholders have also granted the underwriters a 30-day option to purchase up to an additional 1,260,326 shares of Common Stock on the same terms and conditions. The offering is expected to close on or about December 16, 2025, subject to customary closing conditions. Legence is not selling any shares of Common Stock in the offering and will not receive any proceeds from the sale of shares by the Selling Stockholders. Goldman...

PALO ALTO, Calif., Dec. 11, 2025 (GLOBE NEWSWIRE) — Wealthfront, a tech-driven financial platform helping digital natives turn their savings into wealth, today announced the pricing of its initial public offering of 34,615,384 shares of its common stock at a public offering price of $14.00 per share. The offering consists of 21,468,038 shares of common stock being offered by Wealthfront and 13,147,346 shares of common stock being offered by existing stockholders (the “Selling Stockholders”). Wealthfront will not receive any proceeds from the sale of shares by the Selling Stockholders. The shares are expected to begin trading on the Nasdaq Global Select Market on December 12, 2025 under the ticker symbol “WLTH.” The offering is expected to close on December 15, 2025, subject to the satisfaction of customary closing conditions. In...

Taipei, Taiwan., Dec. 11, 2025 (GLOBE NEWSWIRE) — Miluna Acquisition Corp (NASDAQ: MMTXU) (the “Company”), a blank check company formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses, today announced that holders of the Company’s units may elect to separately trade the ordinary shares and warrants included in its units commencing on or about December 15, 2025. The ordinary shares and warrants will trade on the NASDAQ Global Market (“NASDAQ”) under the symbols “MMTX” and “MMTXW”, respectively. Units not separated will continue to trade on NASDAQ under the symbol “MMTXU”. About Miluna Acquisition Corp Miluna Acquisition Corp is a blank check company formed for the purpose of effecting a merger, share exchange,...

VANCOUVER, British Columbia, Dec. 11, 2025 (GLOBE NEWSWIRE) — Miata Metals Corp. (CSE: MMET) (FSE: 8NQ) (OTCQB: MMETF) (“Miata” or the “Company”) is pleased to announce that all matters brought before the Company’s Annual General Meeting held on December 11, 2025 (the “Meeting”) were approved. A total of 23,724,181 common shares of the company were represented at the Meeting, representing 29.70% of the Company’s outstanding common shares as at the record date of November 4, 2025. About Miata Metals Corp. Miata Metals Corp. (CSE: MMET) is a Canadian mineral exploration company listed on the Canadian Securities Exchange, as well as the OTCQB (OTCQB: MMETF) and Frankfurt (FSE: 8NQ) Exchanges. The Company is focused on the acquisition, exploration, and development of mineral properties. The Company holds a 70% interest in the...

NOT FOR DISSEMINATION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES This news release constitutes a “designated news release” for the purposes of Sienna’s amended and restated prospectus supplement dated November 14, 2025 to its short form base shelf prospectus dated November 29, 2024. MARKHAM, Ontario, Dec. 11, 2025 (GLOBE NEWSWIRE) — Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) announced today that it has agreed to issue $250 million aggregate principal amount of series F senior unsecured debentures (the “Debentures”). The Debentures, which will be issued at par, will bear interest at a rate of 3.524% per annum and will mature on December 18, 2028. The Debentures are being offered (the “Offering”) on a best efforts agency basis by a syndicate of agents co-led by BMO Nesbitt Burns Inc.,...

NEW YORK, Dec. 11, 2025 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that an independent peer-reviewed comparative analysis of efficacy and safety between remestemcel-L and ruxolitinib for treatment of steroid-refractory acute graft versus host disease (SR-aGvHD) was presented at the 67th ASH Annual meeting in Florida this past week. The independent study authors concluded that remestemcel-L showed superior outcomes in complete and overall remission compared with ruxolitinib.1 The meta-analysis involved 2,732 patients (1,993 in the treatment arms and 523 in the control arms) across 11 studies. Among treatment groups, 644 patients received remestemcel-L and 1,349 received ruxolitinib. While both ruxolitinib and remestemcel-L...